|
RelenzaDrug - Relenza The trade name of the product as shown on the labeling.
Dosage -
POWDER; INHALATION
Active Ingredient(s) -
Zanamivir
Strength -
5MG
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
021036
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jul 26, 1999
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Smithkline Beecham (cork) Ltd. Dba Glaxosmithkline
Relenza
Sonata 10mg Capsule; Oral
Sonata 5mg Capsule; Oral Relenza 5mg Powder; Inhalation Xeneisol 18-25mci/amp Solution; Inhalation, Injection Xylo-pfan 25gm/bot Powder; Oral Xylose 25gm/bot Powder; Oral Accolate 10mg Tablet; Oral Accolate 20mg Tablet; Oral Hivid 0.375mg Tablet; Oral Hivid 0.75mg Tablet; Oral NewDrugInformation |